Ancora Advisors, LLC Navidea Biopharmaceuticals, Inc. Transaction History

Ancora Advisors, LLC

  • $4.06 Billion
  • Q1 2025

A detailed history of Ancora Advisors, LLC transactions in Navidea Biopharmaceuticals, Inc. stock. As of the latest transaction made, Ancora Advisors, LLC holds 100 shares of NAVB stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$0
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$0.0 - $0.0 $0 - $0
100 New
100 $0

Others Institutions Holding NAVB

# of Institutions
3
Shares Held
10.1K
Call Options Held
0
Put Options Held
0
View Full List

About NAVIDEA BIOPHARMACEUTICALS, INC.

NAVB Quotes by TradingView
  • Ticker NAVB
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,150,900
  • Description
  • Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expr...
More about NAVB
Track This Portfolio

Track Ancora Advisors, LLC Portfolio

Follow Ancora Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ancora Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email